Strong influenza-induced T(FH) generation requires CD4 effectors to recognize antigen locally and receive signals from continuing infection

por Devarajan, Priyadharshini, Vong, Allen M., Castonguay, Catherine H., Kugler-Umana, Olivia, Bautista, Bianca L., Jones, Michael C., Kelly, Karen A., Xia, Jingya, Swain, Susan L.
Publicado 2022

Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)

por Riess, Jonathan W, Reckamp, Karen L, Frankel, Paul, Longmate, Jeffrey, Kelly, Karen A, Gandara, David R, Weipert, Caroline M, Raymond, Victoria M, Keer, Harold N, Mack, Philip C, Newman, Edward M, Lara, Primo N
Publicado 2021